Psychiatric and Neurocognitive Adverse Events in Young Users of Nonmedical Nitrous Oxide.

IF 2.8 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Margot Lestienne, Alexandra Macgregor, Laurie Surig, Hélène Donnadieu, Etienne Mondesert, Céline Eiden, Hélène Peyrière
{"title":"Psychiatric and Neurocognitive Adverse Events in Young Users of Nonmedical Nitrous Oxide.","authors":"Margot Lestienne, Alexandra Macgregor, Laurie Surig, Hélène Donnadieu, Etienne Mondesert, Céline Eiden, Hélène Peyrière","doi":"10.1097/JCP.0000000000002070","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose/background: </strong>For several years, an increase in the nonmedical use of nitrous oxide (N 2 O) has been observed in France, among adolescents and young adults, sometimes associated with severe adverse events.</p><p><strong>Methods/procedures: </strong>Analysis of spontaneous reports (SRs) concerning neuropsychiatric adverse events in N 2 O users, received by the Montpellier addictovigilance centre between 2022 and June 2024, and discussion of the underlying pharmacological mechanisms.</p><p><strong>Findings/results: </strong>Nineteen severe SRs were analysed, mainly in men (73.6%, mean age: 23.1 ± 7.3 y) and concerned psychiatric disorders (n = 11), neurocognitive disorders (n = 2), or both (n = 6). Associated consumptions were mainly cannabis (38.9%). Reported symptoms were psychiatric (mainly behavioural disorders, n = 14; delusion, n = 10), and/or neurocognitive (mainly memory disorders, n = 5; spatiotemporal disorientation, n = 3; cognitive slowing, n = 3).Vitamin B12 dosage was performed in 11 cases (<145 pmol/l: 4 cases, mean: 245.4 ± 118 pmol/l), homocysteine in 10 cases (>15 μmol/l: all cases, mean: 80.3 ± 54 μmol/l), methylmalonic acid in 6 cases (>0.5 μmol/l: 4 cases, mean: 1.2 ± 1.7 μmol/l), and vitamin B9 (<8.83 nmol/l: 2 cases, mean: 16.2 ± 9.7 nmol/l). When performed (n = 8), magnetic resonance imaging revealed white matter abnormalities with punctiform hyperintensities in 6 cases. Twelve have received long-term antipsychotic medication, and 9 vitamin supplementation.N 2 O combines potentially neurotoxic mechanisms: psychoactive (glutamatergic receptor antagonist, opioid/GABAergic effects), biochemical (disruption of vitamin B12 metabolism) and anoxic.</p><p><strong>Implications/conclusions: </strong>These observations highlight the importance and uniqueness of N 2 O-induced neuropsychiatric disorders. N 2 O abuse should be considered in any young patient with psychiatric disorders of unknown origin, particularly when associated with atypical cognitive disorders.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JCP.0000000000002070","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose/background: For several years, an increase in the nonmedical use of nitrous oxide (N 2 O) has been observed in France, among adolescents and young adults, sometimes associated with severe adverse events.

Methods/procedures: Analysis of spontaneous reports (SRs) concerning neuropsychiatric adverse events in N 2 O users, received by the Montpellier addictovigilance centre between 2022 and June 2024, and discussion of the underlying pharmacological mechanisms.

Findings/results: Nineteen severe SRs were analysed, mainly in men (73.6%, mean age: 23.1 ± 7.3 y) and concerned psychiatric disorders (n = 11), neurocognitive disorders (n = 2), or both (n = 6). Associated consumptions were mainly cannabis (38.9%). Reported symptoms were psychiatric (mainly behavioural disorders, n = 14; delusion, n = 10), and/or neurocognitive (mainly memory disorders, n = 5; spatiotemporal disorientation, n = 3; cognitive slowing, n = 3).Vitamin B12 dosage was performed in 11 cases (<145 pmol/l: 4 cases, mean: 245.4 ± 118 pmol/l), homocysteine in 10 cases (>15 μmol/l: all cases, mean: 80.3 ± 54 μmol/l), methylmalonic acid in 6 cases (>0.5 μmol/l: 4 cases, mean: 1.2 ± 1.7 μmol/l), and vitamin B9 (<8.83 nmol/l: 2 cases, mean: 16.2 ± 9.7 nmol/l). When performed (n = 8), magnetic resonance imaging revealed white matter abnormalities with punctiform hyperintensities in 6 cases. Twelve have received long-term antipsychotic medication, and 9 vitamin supplementation.N 2 O combines potentially neurotoxic mechanisms: psychoactive (glutamatergic receptor antagonist, opioid/GABAergic effects), biochemical (disruption of vitamin B12 metabolism) and anoxic.

Implications/conclusions: These observations highlight the importance and uniqueness of N 2 O-induced neuropsychiatric disorders. N 2 O abuse should be considered in any young patient with psychiatric disorders of unknown origin, particularly when associated with atypical cognitive disorders.

非医用氧化亚氮青少年使用者的精神和神经认知不良事件。
目的/背景:几年来,在法国的青少年和年轻人中,观察到一氧化二氮(n2o)的非医疗使用有所增加,有时与严重的不良事件有关。方法/程序:分析蒙彼利埃成瘾警戒中心在2022年至2024年6月期间收到的关于n2o使用者神经精神不良事件的自发报告(SRs),并讨论潜在的药理学机制。结果:共分析了19例严重SRs,主要为男性(73.6%,平均年龄23.1±7.3岁),并伴有精神障碍(n = 11)、神经认知障碍(n = 2)或两者兼有(n = 6)。相关消费主要是大麻(38.9%)。报告的症状是精神疾病(主要是行为障碍,n = 14;妄想,n = 10)和/或神经认知(主要是记忆障碍,n = 5;时空定向障碍,n = 3;认知减缓,n = 3)。11例患者服用维生素B12 (15 μmol/l:所有病例,平均:80.3±54 μmol/l), 6例患者服用甲基丙二酸(0.5 μmol/l: 4例,平均:1.2±1.7 μmol/l),维生素B9(意义/结论:这些观察结果突出了n2诱导的神经精神障碍的重要性和独特性。任何患有不明原因精神疾病的年轻患者,特别是与非典型认知障碍相关的患者,都应考虑滥用n2o。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
3.40%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信